Feed Category: Women's Health Index

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Bavarian Nordic (BVNRY)…

Boston IVF to begin providing FemaSeed as an infertility treatment option to expand access for patients across nearly 30 centers nationwide ATLANTA, Oct. 30, 2024…

Boston IVF to begin providing FemaSeed as an infertility treatment option to expand access for patients across nearly 30 centers nationwide ATLANTA, Oct. 30, 2024…

SYDNEY, AUSTRALIA, Oct. 29, 2024 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3…

SYDNEY, AUSTRALIA, Oct. 29, 2024 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3…

On Friday, Iterum Therapeutics plc (NASDAQ:ITRM) received FDA approval for its Orlynvah (sulopenem etzadroxil and probenecid) for uncomplicated urinary tract infections (uUTIs) caused by the designated…

Nuvectis Pharma (NASDAQ: NVCT) continues to make strides in precision oncology, gaining momentum following presentations last week at the AACR-NCI-EORTC Symposium where its drug candidate…

ORLYNVAH is indicated for the treatment of uUTIs in adult women. Credit: 9nong/Shutterstock. The US Food and Drug Administration (FDA) has approved Iterum Therapeutics‘ new…

A downtrend has been apparent in Shattuck Labs, Inc. (STTK) lately with too much selling pressure. The stock has declined 64.2% over the past four…

NEW YORK, October 24, 2024–(BUSINESS WIRE)–Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in…

DARE-HPV is a potential first-in-category treatment for human papillomavirus (HPV)-related cervical disease which could change the treatment paradigm for clinical HPV management. Essentially all cervical…